Clinical Trial Update: An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal Cancer

View source ↗

Summary

Takeda reports an additional analysis of data from the PARADIGM Exploratory Study in patients with advanced or recurrent colorectal cancer. The trial is listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Takeda | Conditions: Colorectal Cancer | Status: ACTIVE_NOT_RECRUITING